Showing results (2301-2310 of 2,313) with videos related to
Sort By:
Pageof 232
Nature Cancer|June 2, 2022
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stressXihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, et al.Cancer Cell|July 25, 2025
Alistipes finegoldii augments the efficacy of immunotherapy against solid tumorsZhi-Ying Wu, Qi-Wen Wu, Yi Han, et al.Genome Biology and Evolution|October 12, 2020
A Chromosome-Level Genome Assembly of Dendrobium Huoshanense Using Long Reads and Hi-C DataBangxing Han, Yi Jing, Jun Dai, et al.The International Journal of Lower Extremity Wounds|May 15, 2024
Rapid Access From Primary Care to a Multidisciplinary Clinic at Tertiary Care Improves Clinical Outcomes for Patients With Diabetic Foot Ulcers: Results From Diabetic Foot in Primary and Tertiary (DEFINITE) Care's Lower Extremity Amputation Prevention Program (LEAPP) ClinicJaime H X Lin, Lixia Ge, Huiling Liew, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)Feng Wang, Ming-Ming He, Jian Xiao, et al.Nature|September 5, 2024
Perovskite/silicon tandem solar cells with bilayer interface passivationJiang Liu, Yongcai He, Lei Ding, et al.Cell Metabolism|December 11, 2025
Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under immune checkpoint blockadeMing-Ming Wu, Yan-Chao Yang, Zhi-Qiang Hu, et al.Plos Medicine|May 10, 2024
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trialDe-Shen Wang, Chao Ren, Shan-Shan Li, et al.Nature Communications|April 29, 2022
Comprehensive profiling of 1015 patients' exomes reveals genomic-clinical associations in colorectal cancerQi Zhao, Feng Wang, Yan-Xing Chen, et al.Science Advances|October 8, 2025
Ligand-receptor interactions induce and mediate regulatory functions of BATF3+ B cellsHui Yan, Rui Wang, Suryavathi Viswanadhapalli, et al.Pageof 232